Related Experiment Video
Updated: Apr 19, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Tricuspid valve incompetence following implantation of ventricular leads
Giselle A Baquero1, Jerry Luck, Gerald V Naccarelli
1Division of Cardiology, Department of Medicine, Penn State College of Medicine, Penn State Hershey Heart and Vascular Institute, Penn State University, 500 University Drive. Mail Code H047, PO BOX 850, Hershey, PA, 17033, USA, gbaquero@hmc.psu.edu.
Abstract:
Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation III: Medical Management

